Annette Boyle

Atlanta

Staff Writer at BioWorld

Editor at BioWorld MedTech

Experienced medical writer and continuing medical education consultant with Yale MBA.

Featured in: Favicon

bioworld.com Favicon

fiercehealthcare.com Favicon

usmedicine.com Favicon

fiercepharma.com Favicon

clarivate.com

Articles

Sounds of relief as Masimo unloads audio division

1 week ago | bioworld.com | Annette Boyle

Sounds of relief as Masimo unloads audio divisionNews of the sale of Masimo Corp.’s consumer audio unit may be music to the ears of investors, even at the steep discount from its original purchase price. Samsung Electronics Co. Ltd.’s Harman International Industries Inc. unit snapped up the Sound United business for about $350 million – roughly one-third of the $1.025 billion Masimo paid for the company in 2022. BioWorld MedTech Deals and M&A U.S.
Diabetes segment reports good news all around

1 week ago | bioworld.com | Annette Boyle

Diabetes segment reports good news all aroundSenseonics Holdings Inc. and Sequel Med Tech LLC revealed plans to develop an automated insulin delivery system using the Eversense one-year, implantable continuous glucose monitoring system to increase flexibility for people with type 1 diabetes. BioWorld MedTech Diabetes Continuous glucose monitor (CGM) U.S.
Cellecta profiles 19,000 genes from a drop of blood

1 week ago | bioworld.com | Annette Boyle

Home » Cellecta profiles 19,000 genes from a drop of blood BioWorld briefs for May 6, 2025. BioWorld MedTech briefs for May 6, 2025. The U.S. FDA has accepted the NDA for an oral formulation of Novo Nordisk A/S’s Wegovy (semaglutide) in treating obesity. If approved, the daily pill will be the... The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
Med-tech financings and guidance strong despite tariffs

1 week ago | bioworld.com | Annette Boyle

Med-tech financings and guidance strong despite tariffsApril data and first quarter earnings reports show remarkable resilience in med tech, even as other sectors continue to suffer in response to tariffs and changing regulations.
PULSAR gives Kardium legs in PFA horse race

1 week ago | bioworld.com | Annette Boyle

Home » PULSAR gives Kardium legs in PFA horse race BioWorld briefs for May 2, 2025. BioWorld MedTech briefs for May 2, 2025. The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the... The Trump administration’s broad slash to university research budgets raises pertinent questions over impacts to the biopharma ecosystem, specifically how a... BioWorld Asia briefs for April 22, 2025
FDA expands Edwards’ TAVR to asymptomatic severe aortic stenosis

2 weeks ago | bioworld.com | Annette Boyle

FDA expands Edwards’ TAVR to asymptomatic severe aortic stenosisIn a significant boost to the Edwards Lifesciences Corp. Sapien 3 platform’s market opportunity, the U.S. FDA approved use of the transcatheter aortic valve replacement in patients with asymptomatic aortic stenosis. BioWorld MedTech Regulatory Cardiovascular TAVR FDA
Field Medical, Adagio look to VT for break out indication

2 weeks ago | bioworld.com | Annette Boyle

Home » Field Medical, Adagio look to VT for break out indication BioWorld briefs for April 30, 2025. BioWorld MedTech briefs for April 30, 2025. The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the... KRAS mutations are found in more than 90% of pancreatic cancer cases, with the G12D variant being the most prevalent.
PFA continues to set EP hearts aflutter

2 weeks ago | bioworld.com | Annette Boyle

Home » PFA continues to set EP hearts aflutter BioWorld briefs for April 28, 2025. BioWorld MedTech briefs for April 29, 2025. The biggest M&A activity of the year arrived in the form of Merck KGaA’s earlier-disclosed agreement to buy Springworks Therapeutics Inc. for $47 per share in... The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the... Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Fitbit analysis predicts hospitalizations

2 weeks ago | bioworld.com | Annette Boyle

Heart Rhythm 2025Fitbit analysis predicts hospitalizationsUsing step counts and heart rate readings from Google’s Fitbit devices, a machine learning model accurately predicted the risk of hospitalization, a study presented at Heart Rhythm 2025 found. The study used data from participants in the National Institutes of Health’s All of Us research program. BioWorld MedTech Cardiovascular Artificial intelligence Wearable U.S.
HRA/ACC release same-day discharge guidance for cardiac ablation

2 weeks ago | bioworld.com | Annette Boyle

Heart Rhythm 2025HRA/ACC release same-day discharge guidance for cardiac ablationThe Heart Rhythm Society and American College of Cardiology published guidance for same-day discharge of cardiac ablation patients during Heart Rhythm 2025, the society’s annual meeting, which was held in San Diego April 26-27. BioWorld MedTech Clinical Cardiovascular Europe U.S.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers: 102
Tweets: 111
DMs Open: No

Annette Boyle @AnnetteMBoyle

31 Mar 24

Does dude doing the play-by-play on @WElite8 on ABC think he's on the radio? Can he breathe a little more so the women can add the insight that makes it interesting? ESPN is so much better

Annette Boyle @AnnetteMBoyle

11 Mar 22

“The cost of apathy is life, but the price of life is as small as an act of kindness. I am a life preserved by the kindness that was offered to me by others when I could not produce kindness for myself.” Harry Miller @h_miller76

Annette Boyle @AnnetteMBoyle

1 Mar 22

RT @ananavarro: Oof! This was hard to watch. I’ve known @chefjoseandres for many years and am proud to call him a friend. He’s seen awful…